Bioporto A/S

Bioporto A/S OCF Margin

The Operating Cash Flow Margin of Bioporto A/S (BIOPOR.CO) as of Nov 10, 2026 is -191.29 %. In the previous year, Operating Cash Flow Margin was -230.62 % — a change of -17.05% (higher).

OCF Margin

-191.29 %

YoY

-17.05%

Last updated:

Operating Cash Flow Margin of Bioporto A/S is 2025 -191.29 % . Operating Cash Flow Margin of Bioporto A/S was 2024 -230.62 % . It decreases by -17.05% higher compared to the previous year.

The Bioporto A/S OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
-146.10 DKK
Jan 1, 2019
-225.99 DKK
Jan 1, 2020
-153.49 DKK
Jan 1, 2021
-266.25 DKK
Jan 1, 2022
-181.18 DKK
Jan 1, 2023
-179.13 DKK
Jan 1, 2024
-230.62 DKK
Jan 1, 2025
-191.29 DKK
The Bioporto A/S OCF Margin history
YEAROCF MarginYoY
-191.29 %-17.05%
-230.62 %+28.74%
-179.13 %-1.13%
-181.18 %-31.95%
-266.25 %+73.47%
-153.49 %-32.08%
-225.99 %+54.69%
-146.10 %+25.01%
-116.87 %+23.17%
-94.88 %+16.69%
-81.31 %-5.75%
-86.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioporto A/S Stock analysis

What does Bioporto A/S do? Bioporto A/S is a Danish company specializing in the development, production, and sale of diagnostic products for use in medical diagnostics. It was founded in 1999 and is headquartered in Hellerup, near Copenhagen. The company's history is closely connected to the development and marketing of biomarkers and tests. Biomarkers are biological substances that can serve as indicators for certain diseases or health conditions. Bioporto A/S specializes in the identification and development of these biomarkers, playing an important role in medical diagnostics. Its business model is based on the development and production of medical diagnostic products based on the identification of biomarkers. The company focuses on various sectors such as clinical diagnostics, the life science industry, and research and development in the diagnostic field. Bioporto A/S offers a wide range of products that cater to different customer needs. In the field of clinical diagnostics, the company provides a variety of tests and test kits for the identification of biomarkers. These include tests for determining N-terminal prohormones of brain natriuretic peptides (NT-proBNP), a biomarker used in the diagnosis of heart failure, as well as tests for detecting protein C and S, hormone receptors, or Addison's disease. In the life science industry, Bioporto A/S offers products used in the exploration of biomarkers, antibodies, and proteins. This includes antibodies that can be used for protein and protein complex analysis. Research and development of new biomarkers and diagnostic products are of great importance at Bioporto A/S. The company continually invests in the development of new tests and test kits to expand its product range and meet the ever-growing demands of medical diagnostics. Overall, Bioporto A/S is an innovative company playing an important role in medical diagnostics. With its high-quality products and close collaboration with partners in research and development, Bioporto A/S ensures it will continue to play a significant role in the identification and development of biomarkers and diagnostic products in the future. Bioporto A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioporto A/S stock

Operating Cash Flow Margin of Bioporto A/S is -191.29 % in 2025.

Operating Cash Flow Margin of Bioporto A/S changed from -230.62 % to -191.29 %, representing a -17.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Bioporto A/S since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Bioporto A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bioporto A/S

All Key Metrics — Bioporto A/S